We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Please note: V3.0 of the specification is acceptable until 30 June 2018. This version (V3.1) becomes effective on 1 January 2018.
| Version | Description of change | Author | Effective date |
|---|---|---|---|
| V0.90 | Original draft publication for pilot implementation and industry review | Group Support Unit Market Authorisation Group | 01/07/2014 |
| V3.0 | AU eCTD specification for official use. Version 3.0 aligns the numbering for CTD specifications (previously 2.2) and NeeS specifications (previously 1.0) to bring all formats under one version number | Regulatory Operations Unit Market Authorisation Division | 01/04/2015 |
| V3.1 | Updates to provide greater clarity and align with version 3.1 of the AU eCTD specifications and validation criteria. Updates to Envelope Updates to Headers and associated XML elements Additions to Sequence Types and Sequence Descriptions to cater for MMDR recommendations. Split of the Regulatory Activity Lead value 'Prescription' into 'Prescription-chemical' and 'Prescription-biological' Contingent changes to cater for possibility of Work Grouping and Work Sharing Updates to Bookmark/TOC/Hyperlink guidance Consideration for Automation processes and planned portal Updates to Product Information Headings Updates to specific Lifecycle Operations Guidance | Prescription Medicines Authorisation Branch | 01/01/2018 |